Claire Verlaan2020-09-10T12:23:17+02:001 September 2020|RR Mechatronics|
31-08-2020 RR Mechatronics (RRM), despite Corona vicissitudes, was able to maintain its focus in the first half of 2020 and is on track with New Product Development. Dear readers, After a good start to the year 2020, Corona vicissitudes have been influencing our company since March. We immediately took action to ensure the safety of our employees
Claire Verlaan2020-11-10T11:16:08+01:00July 10, 2020|RR Mechatronics|
July 2020 The growth ambitions of RR Mechatronics, medical technology specialist in the development of blood diagnostic instruments for hospitals, laboratories and pharmaceutical companies, are fully on track. The company from Zwaag, whose instruments are used worldwide in large and small laboratories of hospitals, among others, for the measurement and analysis of blood, including
Shyam Kalloe2020-06-30T08:39:47+02:00May 22, 2020|RR Mechatronics|
Medical technology company has sold more Lorrcas so far than in 2019 Zwaag, May 22, 2020 - The growth ambition of RR Mechatronics, medical technology specialist in the development of blood diagnostic instruments for hospitals, laboratories and pharmaceutical companies, is completely on track. The company from Zwaag, whose instruments are used worldwide in large and small laboratories in hospitals, among others
Shyam Kalloe2020-06-04T11:50:16+02:00May 18, 2020|RR Mechatronics|
Zwaag, May 18, 2020 - The management of RR Mechatronics is pleased that more than € 2,2 million has now been subscribed to the 8% bonds. Due to the expected interest, it has been decided to extend the registration period to give potential investors the opportunity to register. The maximum size of the bond loan is € 3.000.000.
Shyam Kalloe2020-06-05T07:24:31+02:00April 16, 2020|RR Mechatronics|
Zwaag, April 16, 2020 - The management of RR Mechatronics is pleased that almost € 1,9 million has now been subscribed to the 8% bonds. Due to the expected interest, it has been decided to extend the registration period to give potential investors the opportunity to register. The maximum size of the bond loan is € 3.000.000. The issuance of bonds
NPEX2020-06-05T07:23:58+02:00November 15 2019|RR Mechatronics|
Hoorn, November 15, 2019 - RR Mechatronics (RRM) has received an FD Gazelle Award for the fastest growing companies in the Netherlands for the fourth time in a row. RR Mechatronics is a medical technology company that focuses entirely on the development and production of laboratory instruments for blood testing. RRM focuses exclusively on the
Shyam Kalloe2020-06-05T07:23:18+02:00July 1, 2019|RR Mechatronics|
INVESTORS OF THE NPEX STOCK EXCHANGE REGISTER RAPIDLY Zwaag, July 1, 2019 - Investors of the NPEX stock exchange have invested €1,5 million within three days in the issuance of bonds of RR Mechatronics, the medical technology specialist in the development of blood diagnostic instruments for hospitals, laboratories and pharmaceutical companies. The 8% subordinated bond loan with a term of 5 years was
Shyam Kalloe2020-06-04T11:41:00+02:00December 18 2018|RR Mechatronics|
Zwaag, December 18, 2018 - RR Mechatronics, which makes blood diagnostic instruments for hospitals and laboratories, wanted to raise 8 million euros with bonds at 3,5% interest. The demand for diagnostic measuring and analyzing equipment for blood is expected to increase sharply in the coming years and to keep up with that growth the company needs extra money
Shyam Kalloe2020-06-04T11:37:36+02:00November 20 2018|RR Mechatronics|
RR Mechatronics to NPEX stock exchange with 8% bond loan RR Mechatronics issues bonds for a maximum of €3,5 million; 8% interest on 5-year subordinated bond; Medical technology: In-Vitro Diagnostics in the hematology segment (blood); Increasing demand for RR Mechatronics equipment from existing and emerging markets; Proceeds from issuing bonds are used for growth
